Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTLA

Portola Pharmaceuticals (PTLA) Stock Price, News & Analysis

Portola Pharmaceuticals logo

About Portola Pharmaceuticals Stock (NASDAQ:PTLA)

Advanced Chart

Key Stats

Today's Range
$18.03
$18.03
50-Day Range
$18.03
$18.03
52-Week Range
$5.31
$31.73
Volume
N/A
Average Volume
3.17 million shs
Market Capitalization
$1.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Portola Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PTLA Stock News Headlines

Portola Middle
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Fault lines in Portola Valley
Portola-Butler Continuation High School
Eagle Pharmaceuticals
See More Headlines

PTLA Stock Analysis - Frequently Asked Questions

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) released its quarterly earnings results on Monday, May, 11th. The biopharmaceutical company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.74) by $0.14. The business's revenue for the quarter was up 18.9% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Portola Pharmaceuticals investors own include Lexicon Pharmaceuticals (LXRX), Novavax (NVAX), Iovance Biotherapeutics (IOVA), Amarin (AMRN), Editas Medicine (EDIT), Exelixis (EXEL) and Geron (GERN).

Company Calendar

Last Earnings
5/11/2020
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PTLA
Fax
N/A
Employees
324
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290.66 million
Net Margins
-232.73%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$116.64 million
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
10.80

Miscellaneous

Free Float
N/A
Market Cap
$1.42 billion
Optionable
Optionable
Beta
2.32
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:PTLA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners